-
In this issue: Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
-
A total of 130 singleton stillbirths from a single institution in Australia, from January 2005 through December 2006, of > 20 weeks gestation with no cause of death and with available formalin-fixed, paraffin-embedded tissues were examined by multiplex PCR for 19 infectious agents, and by immunohistochemistry for human cytomegalovirus (CMV).
-
The authors conducted a series of experiments in which HIV-1 transfected 1G5 T cells were exposed to either a series of known long terminal repeat (TLR) ligands (FimH/TLR-4, flagellin/TLR-5, and poly I:C/TLR-3) or STI pathogens (HSV-1, HSV-2, and N. gonorrhoeae).
-
As mandatory flu immunization policies continue to gain momentum in health care settings, egg allergy one of the classic exemptions to the vaccine is being redefined by public health officials.
-
Infection preventionists at Vanderbilt Medical Center in Nashville have developed a comprehensive glucometer cleaning protocol that other IPs may want to emulate as regulators respond to outbreaks of hepatitis B virus in diabetics and other patients.
-
A clinic in Madison, WI has contacted 2,345 patients to advise them they may have been exposed to bloodborne pathogens after finding an employee was inappropriately using insulin pens and finger stick devices during patient training.
-
The following FAQs summarize inquiries from healthcare personnel received by the Centers for Disease Control & Prevention regarding best practices for performance of assisted blood glucose monitoring and insulin administration.
-
The Centers for Disease Control and Prevention recommends the following infection prevention measures for blood glucose monitoring and insulin administration.
-
A key advisory committee to the Centers for Disease Control and Prevention is expected to recommend that millions of diabetics be immunized against hepatitis B virus, a move that could finally halt the recurrent and deadly HBV outbreaks linked to needles and devices used in glucose monitoring in a variety of healthcare settings, Hospital Infection Control & Prevention has learned.
-
The Centers for Medicare and Medicaid Services (CMS) the single largest payer for health care in the United States is creating a hospital inspection program focused specifically on infection control, Hospital Infection Control & Prevention has learned.
